VANCOUVER, BC – InMed Pharmaceuticals Inc. (NASDAQ: INM) (“InMed” or the “Company“), a pharmaceutical company focused on developing a pipeline of proprietary small molecule drug candidates for diseases with high… Read More
UBC Medicine professor Dr. Laura Evgin has been selected as one of the 2024 Canada Gairdner Early Career Investigators for her work in CAR T-cell therapy. Dr. Evgin is an… Read More
VANCOUVER, BC – Doctors and researchers in cancer clinics and labs across the country will spend the next year following “patients’ orders” rather than the other way around after receiving… Read More
Toronto, ON – Innovative Medicines Canada (IMC) welcomes the collective agreement amongst Canada’s Premiers to take meaningful action that speeds up approvals for life-saving medications, as announced by Premier Doug Ford… Read More
BURNABY, BC – Qu Biologics Inc., a clinical stage biopharmaceutical company developing Site Specific Immunomodulators (SSIs), a novel platform of immunotherapies designed to restore innate immune function, is pleased to… Read More
